Skip to main content
73-87% of autoimmune (RA, SLE, UCTD, APL) pts used HCQ during pregnancy. HCQ significantly reduced pre-eclampsia (20% vs

Dr. John Cush RheumNow

3 years 10 months ago
73-87% of autoimmune (RA, SLE, UCTD, APL) pts used HCQ during pregnancy. HCQ significantly reduced pre-eclampsia (20% vs 9%), early-onset pre-eclampsia (8% vs 2.5%), 2nd/3rd trimester pregnancy loss (3% vs. 0.6%) https://t.co/CF5ivHeCmY https://t.co/CYqaCCuZJz
Fever, FROST, & Pericarditis

Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow

Dr. John Cush RheumNow

3 years 10 months ago
Fever, FROST, & Pericarditis Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK. https://t.co/IFxocGkOxJ https://t.co/OzoS248ZRK
Review of the Rheumatic causes of Pericarditis and their management. Causes: SLE, RA, MCTD, Myositis, EGPA, GPA, IgG4-r

Dr. John Cush RheumNow

3 years 10 months ago

Review of the Rheumatic causes of Pericarditis and their management. Causes: SLE, RA, MCTD, Myositis, EGPA, GPA, IgG4-rel Dz, FMF, TRAPS, CAPS, AOSD, JIA, Sarcoidosis, Kawasakis, GCA, Takayasu's https://t.co/MQmkUe4Yey https://t.co/FSfrznoeBe

JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD

The occurrence of interstitial lung disease (ILD) in Syste

Dr. John Cush RheumNow

3 years 10 months ago
JAK Inhibitor Potential in Systemic Sclerosis-Associated ILD The occurrence of interstitial lung disease (ILD) in Systemic sclerosis portends serious morbid and mortal outcomes for those affected. https://t.co/LWHKO0gRu4 https://t.co/i2IOLcAgt3
CXCL5 Therapy in Lupus?

A new study has shown that restoring the balance of a protein in blood may be a promising trea

Dr. John Cush RheumNow

3 years 10 months ago
CXCL5 Therapy in Lupus? A new study has shown that restoring the balance of a protein in blood may be a promising treatment option for systemic lupus erythematosus, or lupus, an incurable autoimmune disease. https://t.co/B82Xq5FFNJ. https://t.co/ba2nlFuDsI
Low dose steroids can negatively impact bone health

Dr. Janet Pope discusses abstract L01 presented at ACR22.

https:/

Dr. John Cush RheumNow

3 years 10 months ago
Low dose steroids can negatively impact bone health Dr. Janet Pope discusses abstract L01 presented at ACR22. https://t.co/eBGMza9tWE https://t.co/wACnLTxATu
The First Head to Head trial in Axial SpA

Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukin

Dr. John Cush RheumNow

3 years 10 months ago
The First Head to Head trial in Axial SpA Dr.Gensler discusses abstract L15 presented at #ACR22. L15: Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with Radiographic AxSpA: A Randomized Phase IIIb Study https://t.co/RgwKRJwgoS https://t.co/6LxOURICiE
Marginal Benefit with Diet and Exercise in Obese Knee Osteoarthritis Patients

The easiest intervention for knee osteoar

Dr. John Cush RheumNow

3 years 10 months ago
Marginal Benefit with Diet and Exercise in Obese Knee Osteoarthritis Patients The easiest intervention for knee osteoarthritis (diet and exercise) is also the most difficult for many patients; but do these work? https://t.co/s4Gzmh2gGZ https://t.co/aZORTMtCvs
Dr. Jack Frost reviews the news, and journal articles from the past week on RheumNow and ends with an audience question on "Macro-CK".
Nature Reviews Rheumatology features a review of three notable papers that address the impact of SARS-CoV-2 vaccination on people with inflammatory rheumatic disease. 
Get the Skinny on Bimekizumab in PsA

Dr. Janet Pope discusses abstract presented at #ACR22.

https://t.co/FKFARxQ2fa h

Dr. John Cush RheumNow

3 years 10 months ago
Get the Skinny on Bimekizumab in PsA Dr. Janet Pope discusses abstract presented at #ACR22. https://t.co/FKFARxQ2fa https://t.co/wSyXeSHII3
During 2021–22 FLU season, 6% of hosp pedi-influenza pts had SARS-CoV-2 coinfection; these required more respiratory s

Dr. John Cush RheumNow

3 years 10 months ago
During 2021–22 FLU season, 6% of hosp pedi-influenza pts had SARS-CoV-2 coinfection; these required more respiratory support. Risk of influenza death augmented by not recv vaccination (flu or covid), no antiviral Rx, comorbidities & coinfx w/COVID https://t.co/bfjeClHflW https://t.co/YTOEnNSQQN
Lupus Research Alliance announced 2022 Distinguished Innovator Award recipients:
- Hongbo Chi, PhD, Exploring Metabolis

Dr. John Cush RheumNow

3 years 10 months ago
Lupus Research Alliance announced 2022 Distinguished Innovator Award recipients: - Hongbo Chi, PhD, Exploring Metabolism of Follicular Helper T Cells & Lupus Progression - Joseph Craft, MD: Processes Enabling T Cells to Be Destructive in Lupus Nephritis https://t.co/yI2NlCHaBi https://t.co/fevBTkaxCY
×